Please assess the completion status of the following clinical trial:

Trial Title: Understanding Visual Confusion Using Stereoscopic Displays

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Better than 20/40 visual acuity in the worse eye~* No restrictions of the peripheral visual field: (at least 60 degrees vertically and 40 degrees horizontally)~* At least 14 years of age (no upper age limit)~* Able to give voluntary, informed consent~* Able to understand English~* Binocular vision parameters within normal limits (Stereopsis ≤ 100 arc sec on any stereo test)~Exclusion criteria:~* Patients with any physical or mental disabilities, including cognitive dysfunction, balance problems, or other deficits that could impair their ability to respond to the stimuli presented in this study will be excluded~* Being unable to complete sessions lasting 2-3 hours

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Visual confusion (Type: EXPERIMENTAL): Participants viewed peripheral targets in three different visual confusion conditions (three interventions): binocular visual confusion (unilateral opaque target), unilateral monocular visual confusion (unilateral see-through target), and bilateral monocular visual confusion (bilateral see-through target). Each intervention was presented twice in a randomized order, resulting in a total of six trials. During each trial, a peripheral target was presented in front of a forward-moving background for one minute. Participants were instructed to hold down the controller button while the target was visible and release it when a third or more of the target disappeared. After each trial, participants could take a brief break before the next trial in a different visual confusion condition was presented in a randomized order.

Based on this trial design, predict the completion outcome and termination type (if applicable).